Raymond James & Associates’s Innovator US Equity Buffer ETF November BNOV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
$4.27M Sell
111,958
-5,183
-4% -$195K ﹤0.01% 1761
2024
Q2
$4.38M Sell
117,141
-334
-0.3% -$12.3K ﹤0.01% 1673
2024
Q1
$4.29M Sell
117,475
-1,076
-0.9% -$38.4K ﹤0.01% 1696
2023
Q4
$4.14M Buy
118,551
+97,341
+459% +$3.26M ﹤0.01% 1660
2023
Q3
$694K Sell
21,210
-801
-4% -$27.2K ﹤0.01% 2680
2023
Q2
$748K Hold
22,011
﹤0.01% 2661
2023
Q1
$696K Hold
22,011
﹤0.01% 2706
2022
Q4
$655K Buy
+22,011
New +$653K ﹤0.01% 2702

Other funds holding BNOV

Raymond James & Associates's BNOV Position: Q3 2024 in Review

Raymond James & Associates reduced its Innovator US Equity Buffer ETF November (BNOV) stake by 4.4% in Q3 2024, selling an estimated $195K and leaving 111,958 shares worth $4.27M. The position accounts for ﹤0.01% of the portfolio, ranked #1761.

Raymond James & Associates first reported a position in BNOV in Q4 2022 and has held it in 8 quarters since. The position peaked at $4.38M in Q2 2024. 71 funds tracked by Wall St. Rank hold BNOV as of Q3 2024.

  • Raymond James & Associates held 111,958 shares of Innovator US Equity Buffer ETF November worth $4.27M as of Q3 2024.
  • Raymond James & Associates sold 5,183 Innovator US Equity Buffer ETF November shares in Q3 2024, an estimated $195K.
  • Innovator US Equity Buffer ETF November made up ﹤0.01% of Raymond James & Associates's portfolio in Q3 2024, its #1761 holding.
  • Raymond James & Associates first reported a position in Innovator US Equity Buffer ETF November in Q4 2022 and has held it in 8 quarters since.
  • Raymond James & Associates's Innovator US Equity Buffer ETF November position peaked at $4.38M in Q2 2024.
  • 71 funds tracked by Wall St. Rank held Innovator US Equity Buffer ETF November as of Q3 2024.

Based on Raymond James & Associates's 13F filing for Q3 2024, filed 18 Oct 2024.